Mass spectrometry-based proteomic analysis of proteins adsorbed by hexadecyl-immobilized cellulose bead column for the treatment of dialysis-related amyloidosis

References

• Harding JL, Morton JI, Shaw JE, et al. Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia. Nephrol Dial Transplant. 2022;37(10):2004–2013. doi: 10.1093/ndt/gfab315.
   PubMed Web of Science ®Google Scholar
• Johansen KL, Chertow GM, Foley RN, et al. US Renal Data System 2020 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2021;77(4 Suppl. 1):A7–A8. doi: 10.1053/j.ajkd.2021.01.002.
   PubMed Web of Science ®Google Scholar
• Nitta K, Goto S, Masakane I, et al. Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Ren Replace Ther. 2020;6(1):41. doi: 10.1186/s41100-020-00286-9.
   Google Scholar
• Unruh ML, Hess R. Assessment of health-related quality of life among patients with chronic kidney disease. Adv Chronic Kidney Dis. 2007;14(4):345–352. doi: 10.1053/j.ackd.2007.07.011.
   PubMed Web of Science ®Google Scholar
• Gejyo F, Yamada T, Odani S, et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun. 1985;129(3):701–706. doi: 10.1016/0006-291x(85)91948-5.
   PubMed Web of Science ®Google Scholar
• Gejyo F, Arakawa M. Dialysis amyloidosis: current disease concepts and new perspectives for its treatment. Contrib Nephrol. 1990;78:47–60, discussion 59–60. doi: 10.1159/000418269.
   PubMedGoogle Scholar
• Charra B, Calemard E, Uzan M, et al. Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term haemodialysis patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:291–295.
   PubMedGoogle Scholar
• Koch KM. Dialysis-related amyloidosis. Kidney Int. 1992;41(5):1416–1429. doi: 10.1038/ki.1992.207.
   PubMed Web of Science ®Google Scholar
• Portales-Castillo I, Yee J, Tanaka H, et al. Beta-2 microglobulin amyloidosis: past, present, and future. Kidney360. 2020;1(12):1447–1455. doi: 10.34067/KID.0004922020.
   PubMedGoogle Scholar
• Gejyo F, Kawaguchi Y, Hara S, et al. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column. Artif Organs. 2004;28(4):371–380. doi: 10.1111/j.1525-1594.2004.47260.x.
   PubMed Web of Science ®Google Scholar
• Gejyo F, Amano I, Ando T, et al. Survey of the effects of a column for adsorption of beta2-microglobulin in patients with dialysis-related amyloidosis in Japan. Ther Apher Dial. 2013;17(1):40–47. doi: 10.1111/j.1744-9987.2012.01130.x.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Hirawa N, Yamaguchi S, et al. Long-term efficacy and safety of the small-sized beta2-microglobulin adsorption column for dialysis-related amyloidosis. Ther Apher Dial. 2011;15(5):466–474. doi: 10.1111/j.1744-9987.2011.00937.x.
   PubMed Web of Science ®Google Scholar
• Abe T, Uchita K, Orita H, et al. Effect of beta(2)-microglobulin adsorption column on dialysis-related amyloidosis. Kidney Int. 2003;64(4):1522–1528. doi: 10.1046/j.1523-1755.2003.00235.x.
   PubMed Web of Science ®Google Scholar
• Kutsuki H. Beta(2)-microglobulin-selective direct hemoperfusion column for the treatment of dialysis-related amyloidosis. Biochim Biophys Acta. 2005;1753(1):141–145. doi: 10.1016/j.bbapap.2005.08.007.
   PubMed Web of Science ®Google Scholar
• Tsuchida K, Takemoto Y, Nakamura T, et al. Lixelle adsorbent to remove inflammatory cytokines. Artif Organs. 1998;22(12):1064–1067. doi: 10.1046/j.1525-1594.1998.06179.x.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Sato M, Sato Y, et al. Adsorption of protein-bound uremic toxins through direct hemoperfusion with hexadecyl-immobilized cellulose beads in patients undergoing hemodialysis. Artif Organs. 2018;42(1):88–93. doi: 10.1111/aor.12961.
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Nameta M, Kuwano M, et al. Proteomic approach to human kidney glomerulus prepared by laser microdissection from frozen biopsy specimens: exploration of proteome after removal of blood-derived proteins. Proteomics Clin Appl. 2012;6(7–8):412–417. doi: 10.1002/prca.201200016.
   PubMed Web of Science ®Google Scholar
• Hirao Y, Saito S, Fujinaka H, et al. Proteome profiling of diabetic mellitus patient urine for discovery of biomarkers by comprehensive MS-based proteomics. Proteomes. 2018;6(1):9. doi: 10.3390/proteomes6010009.
   PubMedGoogle Scholar
• Griffin NM, Yu J, Long F, et al. Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol. 2010;28(1):83–89. doi: 10.1038/nbt.1592.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi: 10.1038/s41467-019-09234-6.
   PubMed Web of Science ®Google Scholar
• Nakajima K, Yamaguchi K, Noji M, et al. Macromolecular crowding and supersaturation protect hemodialysis patients from the onset of dialysis-related amyloidosis. Nat Commun. 2022;13(1):5689. doi: 10.1038/s41467-022-33247-3.
   PubMed Web of Science ®Google Scholar
• Myers SL, Jones S, Jahn TR, et al. A systematic study of the effect of physiological factors on beta2-microglobulin amyloid formation at neutral pH. Biochemistry. 2006;45(7):2311–2321. doi: 10.1021/bi052434i.
   PubMed Web of Science ®Google Scholar
• Yamaguchi I, Hasegawa K, Takahashi N, et al. Apolipoprotein E inhibits the depolymerization of beta 2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry. 2001;40(29):8499–8507. doi: 10.1021/bi0027128.
   PubMed Web of Science ®Google Scholar
• Beck B, Chen YF, Dere W, et al. Assay operations for SAR support. In: Markossian S, Grossman A, Brimacombe K, editors. Assay guidance manual. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004.
   Google Scholar
• Buxbaum JN, Dispenzieri A, Eisenberg DS, et al. Amyloid Nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2022;29(4):213–219. doi: 10.1080/13506129.2022.2147636.
   PubMed Web of Science ®Google Scholar
• Naiki H, Okoshi T, Ozawa D, et al. Molecular pathogenesis of human amyloidosis: lessons from beta2-microglobulin-related amyloidosis. Pathol Int. 2016;66(4):193–201. doi: 10.1111/pin.12394.
   PubMed Web of Science ®Google Scholar
• Yamamoto S. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on beta(2)-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis—Oshima Award Address 2016. Clin Exp Nephrol. 2019;23(2):151–157. doi: 10.1007/s10157-018-1588-9.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Yamaguchi I, Hasegawa K, et al. Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. J Am Soc Nephrol. 2004;15(1):126–133. doi: 10.1097/01.asn.0000103228.81623.c7.
   PubMed Web of Science ®Google Scholar
• Relini A, De Stefano S, Torrassa S, et al. Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen. J Biol Chem. 2008;283(8):4912–4920. doi: 10.1074/jbc.M702712200.
   PubMed Web of Science ®Google Scholar
• Hoop CL, Zhu J, Bhattacharya S, et al. Collagen I weakly interacts with the beta-sheets of beta(2)-microglobulin and enhances conformational exchange to induce amyloid formation. J Am Chem Soc. 2020;142(3):1321–1331. doi: 10.1021/jacs.9b10421.
   PubMed Web of Science ®Google Scholar
• Ookoshi T, Hasegawa K, Ohhashi Y, et al. Lysophospholipids induce the nucleation and extension of beta2-microglobulin-related amyloid fibrils at a neutral pH. Nephrol Dial Transplant. 2008;23(10):3247–3255. doi: 10.1093/ndt/gfn231.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Tsutsumi-Yasuhara S, Ookoshi T, et al. Growth of beta(2)-microglobulin-related amyloid fibrils by non-esterified fatty acids at a neutral pH. Biochem J. 2008;416(2):307–315. doi: 10.1042/BJ20080543.
   PubMedGoogle Scholar
• Zhang CM, Yamaguchi K, So M, et al. Possible mechanisms of polyphosphate-induced amyloid fibril formation of beta(2)-microglobulin. Proc Natl Acad Sci U S A. 2019;116(26):12833–12838. doi: 10.1073/pnas.1819813116.
   PubMed Web of Science ®Google Scholar
• Kuragano T, Inoue T, Yoh K, et al. Effectiveness of beta(2)-microglobulin adsorption column in treating dialysis-related amyloidosis: a multicenter study. Blood Purif. 2011;32(4):317–322. doi: 10.1159/000330332.
   PubMed Web of Science ®Google Scholar
• Nakano T, Nagae H, Murakami N, et al. Fever associated with severe dialysis-related amyloidosis. CEN Case Rep. 2012;1(2):112–116. doi: 10.1007/s13730-012-0024-3.
   PubMedGoogle Scholar
• Sultana MF, Abo H, Kawashima H. Human and mouse angiogenins: emerging insights and potential opportunities. Front Microbiol. 2022;13:1022945. doi: 10.3389/fmicb.2022.1022945.
   PubMed Web of Science ®Google Scholar
• Khaledian B, Thibes L, Shimono Y. Adipocyte regulation of cancer stem cells. Cancer Sci. 2023;114(11):4134–4144. doi: 10.1111/cas.15940.
   PubMed Web of Science ®Google Scholar
• Duranton F, Cohen G, De Smet R, et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012;23(7):1258–1270. doi: 10.1681/ASN.2011121175.
   PubMed Web of Science ®Google Scholar
• Kaur R, Singh R. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications. Life Sci. 2022;311(Pt B):121148. doi: 10.1016/j.lfs.2022.121148.
   PubMedGoogle Scholar